On Friday, HCA Healthcare Inc (NYSE: HCA) opened lower -0.76% from the last session, before settling in for the closing price of $324.53. Price fluctuations for HCA have ranged from $289.98 to $417.14 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 6.69%. Company’s average yearly earnings per share was noted 13.22% at the time writing. With a float of $180.75 million, this company’s outstanding shares have now reached $253.30 million.
Considering the fact that the conglomerate employs 310000 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 50.04%, operating margin of 15.08%, and the pretax margin is 12.55%.
HCA Healthcare Inc (HCA) Insider Activity
A key investor’s attitude towards the stock of the Medical Care Facilities industry is another important factor to consider. The insider ownership of HCA Healthcare Inc is 28.54%, while institutional ownership is 63.61%. The most recent insider transaction that took place on Jan 31 ’25, was worth 1,082,203. Before that another transaction happened on Nov 14 ’24, when Company’s SVP & Chief Ethics Officer sold 1,474 for $357.99, making the entire transaction worth $527,677. This insider now owns 9,454 shares in total.
HCA Healthcare Inc (HCA) Earnings and Forecasts
Wall Street market experts anticipate that the next fiscal year will bring earnings of 6.32 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 13.22% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.16% during the next five years compared to 16.93% growth over the previous five years of trading.
HCA Healthcare Inc (NYSE: HCA) Trading Performance Indicators
Check out the current performance indicators for HCA Healthcare Inc (HCA). In the past quarter, the stock posted a quick ratio of 0.97. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.16. Likewise, its price to free cash flow for the trailing twelve months is 14.47.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 21.99, a number that is poised to hit 5.78 in the next quarter and is forecasted to reach 27.96 in one year’s time.
Technical Analysis of HCA Healthcare Inc (HCA)
Compared to the last year’s volume of 1.68 million, its volume of 1.47 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 46.93%. Additionally, its Average True Range was 9.29.
During the past 100 days, HCA Healthcare Inc’s (HCA) raw stochastic average was set at 25.22%, which indicates a significant decrease from 41.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 38.47% in the past 14 days, which was higher than the 28.90% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $315.35, while its 200-day Moving Average is $345.32. Nevertheless, the first resistance level for the watch stands at $326.66 in the near term. At $331.26, the stock is likely to face the second major resistance level. The third major resistance level sits at $333.99. If the price goes on to break the first support level at $319.33, it is likely to go to the next support level at $316.60. Should the price break the second support level, the third support level stands at $312.00.
HCA Healthcare Inc (NYSE: HCA) Key Stats
There are currently 253,297K shares outstanding in the company with a market cap of 81.57 billion. Presently, the company’s annual sales total 70,603 M according to its annual income of 5,760 M. Last quarter, the company’s sales amounted to 18,285 M and its income totaled 1,438 M.
